Panacea Biotec logo

Panacea Biotec MD, chairman, board of directors and AGM

NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap

Last close ₹311.45down ₹15.35 (4.70%)BSE ₹311.40

Share price at the NSE close on 23 Oct 2026. Previous close ₹326.80.

52-week range of traded prices to 23 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
Market cap
₹1,908 Cr1,088th largest listed
P/E
Lossover the last 12 months
P/B
2.3
Dividend yield
Nonein the last 12 months
ROE
−0.9%
ROE without one-offs
−2.2%
ROCE
−3.6%
Debt to equity
0.03
Volume, NSE
82,88547.4% delivered

Panacea Biotec board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorRajesh Jain
  • Company Secretary and Compliance OfficerAnkit Jain

9 directors4 independent5 executive

  • Rajesh Jain · Chairperson and managing directorExecutive · joined Nov 1984 · reappointed Jan 2025 · 1 listed board
  • Sandeep JainExecutive · joined Nov 1984 · reappointed Apr 2025 · 1 listed board · 1 committee seat
  • Ankesh JainExecutive · joined Apr 2016 · reappointed Apr 2025 · 1 listed board · 1 committee seat
  • Harshet JainExecutive · joined Feb 2025 · reappointed Feb 2025 · 1 listed board
  • Sanjay TrehanExecutive · joined Feb 2025 · reappointed Feb 2025 · 1 listed board · 1 committee seat
  • Ambika SharmaIndependent · joined Feb 2024 · reappointed Feb 2024 · 28 months as independent · 6 listed boards · 6 as independent · 10 committee seats, 2 as chair
  • Krishan Kumar JalanIndependent · joined Feb 2025 · reappointed Feb 2025 · 16 months as independent · 5 listed boards · 5 as independent · 7 committee seats, 2 as chair
  • Rajender Pal SinghIndependent · joined Feb 2025 · reappointed Feb 2025 · 16 months as independent · 2 listed boards · 2 as independent
  • Venkatesh SarvasiddhiIndependent · joined Feb 2025 · reappointed Feb 2025 · 16 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

4 directors who left
  • Mukul Gupta, left 31 Mar 2026: Tenure Completion
  • Narotam Kumar Juneja, left 31 Mar 2025: Tenure Completion
  • Manjula Upadhyay, left 29 Mar 2025: Tenure Completion
  • Bhupinder Singh, left 16 Oct 2024: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 30 May 202610 of 10 present5 independent · 107 days in between
    • 11 Feb 202611 of 11 present6 independent

  • Audit Committee

    Ambika Sharma, Krishan Kumar Jalan

    • 29 May 20263 of 3 present3 independent · 106 days in between
    • 11 Feb 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Ambika Sharma

    Rajender Pal Singh

    • 29 May 20263 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Ambika Sharma

    Sanjay Trehan, Sandeep Jain

    • 29 May 20263 of 3 present1 independent · 107 days in between
    • 10 Feb 20263 of 3 present1 independent

  • Risk Management Committee

    Chair Rajesh Jain

    Sandeep Jain, Ankesh Jain, Sanjay Trehan, Rajender Pal Singh

    • 5 Jun 20264 of 6 present2 independent · 203 days in between
    • 13 Nov 20252 of 5 present0 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s Suresh Surana & Associates LLPPeer-review certificate valid to Mar 2028
1 earlier auditor
  • M/s Suresh Surana & AssociatesNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Panacea Biotec AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Panacea Biotec dividend history

Annual general meeting, 29 Sep 2026

33,612 shareholders on the register on 22 Sep 2026; present: 2 promoters and 60 others; votes counted by Mr. Debabrata Deb Nath / M/s R&D Company Secretaries.The company's voting result (opens in a new tab)

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2026 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2026 including Auditors’ Report thereonMoreLess
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.02% · other public 70.87%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  2. Re-appointment of retiring director viz. Mr. Ankesh Jain
    OrdinaryPromoters have an interest in it
    99.85% for0.15% against

    Against: promoters 0.00% · institutions 1.36% · other public 70.91%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  3. Re-appointment of retiring director viz. Mr. Harshet Jain
    OrdinaryPromoters have an interest in it
    99.85% for0.15% against

    Against: promoters 0.00% · institutions 1.34% · other public 70.91%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  4. Appointment of Independent Director viz. Mr. Rajinder Singh Manku
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 74.45%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2026-27
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 70.89%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Sep 2025, 5 resolutions

34,241 shareholders on the register on 23 Sep 2025; present: 2 promoters and 67 others; votes counted by Mr. Debabrata Deb Nath / M/s R&D Company Secretaries.The company's voting result (opens in a new tab)

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2025 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2025 including Auditors’ Report thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  2. Re-appointment of retiring director Dr. Rajesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  3. Re-appointment of retiring director Mr. Sandeep Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  4. Appointment of M/s R&D Company Secretaries as Secretarial Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Mar 2025, 7 resolutions

34,957 shareholders on the register on 21 Feb 2025; votes counted by Mr. Debabrata Deb Nath / R & D Company Secretaries.The company's voting result (opens in a new tab)

  1. Re-appointment of Mr. Sandeep Jain (DIN: 00012973) as Joint Managing Director for a period of 3 years w.e.f. April 01, 2025
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  2. Re-appointment of Mr.Ankesh Jain (DIN: 03556647) as Whole-time Director for a period of 5 years w.e.f. April 01, 2025.
    OrdinaryPromoters have an interest in it
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 100.00% · other public 0.13%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  3. Appointment of Mr. Harshet Jain (DIN: 08732974) as Whole-time Director for a period of 3 years w.e.f. February 14, 2025.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  4. Appointment of Dr. Sanjay Trehan (DIN:10936402) as Whole-time Director for a period of 3 years w.e.f. February 14, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.13%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  5. Appointment of Mr. Krishan Kumar Jalan (DIN: 01767702) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.14%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  6. Appointment of Dr. Rajender Pal Singh (DIN: 10198810) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.14%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  7. Appointment of Mr. Venkatesh Sarvasiddhi (DIN: 09326552) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.31%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Dec 2024, 3 resolutions

36,776 shareholders on the register on 22 Nov 2024; votes counted by Debabrata Deb Nath / R&D Company Secretaries.The company's voting result (opens in a new tab)

  1. Re-appointment of Dr. Rajesh Jain (DIN: 00013053) as Chairman and Managing Director for a period of 3 years w.e.f. January 01, 2025
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

  2. Appointment of Mr. Rajesh Jain (DIN: 10619014), Chartered Accountant as a non-executive Independent Director for a period of 5 consecutive years w.e.f. November 13, 2024
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.29%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

  3. Approval for making donation / contribution to bonafide and Charitable Trust
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 100.00% · other public 2.57%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Sep 2024, 5 resolutions

Present: 2 promoters and 61 others.The company's voting result (opens in a new tab)

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2024 and b) Audited Consolidated Financial Statements for financial year ended March 31, 2024 and the report of Board of Director and Auditors.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.20%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  2. Re-appointment of retiring director i.e. Mr. Narotam Kumar Juneja, for a period upto March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  3. Appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors and fixation of their remuneration
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.24%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  4. Consider and approve re-classification from Promoters and Promoters' Group category to Public category
    OrdinaryPromoters have an interest in it
    99.77% for0.23% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.24%

    Turnout: all 0.21% · promoters 0.00% · institutions 0.03% · other public 1.03%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.22%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 11 Apr 2024, 2 resolutions

The company's voting result (opens in a new tab)

  1. Appointment of Mrs. Ambika Sharma (DIN: 08201798) as Non-Executive Independent Director
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.91%

    Turnout: all 79.30% · promoters 99.67% · institutions 0.02% · other public 2.30%

  2. Re-appointment of Mr. Bhupinder Singh (DIN: 00062754) as Non-Executive Independent Director
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.44%

    Turnout: all 79.30% · promoters 99.67% · institutions 0.02% · other public 2.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Sep 2023, 4 resolutions

Present: 2 promoters and 48 others.The company's voting result (opens in a new tab)

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2023 andn(b) Audited Consolidated Financial Statements for financial year ended March 31, 2023:
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.00% · other public 50.91%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  2. Re-appointment of retiring director i.e. Mr. Sandeep Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.67%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  3. Re-appointment of retiring director i.e. Mr. Ankesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.74%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  4. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2023-24:
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.00% · other public 51.54%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Sep 2022, 4 resolutions

Present: 1 promoter and 53 others.The company's voting result (opens in a new tab)

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2022 and (b) Audited Consolidated Financial Statements for financial year ended March 31, 2022:
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  2. Re-appointment of retiring director i.e. Mr. Soshil Kumar Jain
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.08%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  3. Re-appointment of retiring director i.e. Dr. Rajesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.00%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  4. Ratification of remuneration of M/s GT & Co., Cost Auditors for the financial year 2022-23
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.38%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 30 Sep 2025, 2 fund houses

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2025 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2025 including Auditors’ Report thereonMoreLess
    2 for0 against
  • Re-appointment of retiring director Dr. Rajesh Jain
    2 for0 against
  • Re-appointment of retiring director Mr. Sandeep Jain
    2 for0 against
  • Appointment of M/s R&D Company Secretaries as Secretarial Auditors of the Company
    2 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2025-26
    2 for0 against

Mutual fund votes, meeting of 27 Sep 2024, 2 fund houses

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2024 and b) Audited Consolidated Financial Statements for financial year ended March 31, 2024 and the report of Board of Director and Auditors.MoreLess
    2 for0 against
  • Re-appointment of retiring director i.e. Mr. Narotam Kumar Juneja, for a period upto March 31, 2025
    2 for0 against
  • Appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors and fixation of their remuneration
    2 for0 against
  • Consider and approve re-classification from Promoters and Promoters' Group category to Public category
    2 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2024-25
    2 for0 against
3 earlier meetings

Mutual fund votes, meeting of 11 Apr 2024, 1 fund house

  • Appointment of Mrs. Ambika Sharma (DIN: 08201798) as Non-Executive Independent Director
    1 for0 against
  • Re-appointment of Mr. Bhupinder Singh (DIN: 00062754) as Non-Executive Independent Director
    1 for0 against

Mutual fund votes, meeting of 29 Sep 2023, 1 fund house

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2023 andn(b) Audited Consolidated Financial Statements for financial year ended March 31, 2023:
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Sandeep Jain
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Ankesh Jain
    1 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2023-24:
    1 for0 against

Mutual fund votes, meeting of 28 Sep 2022, 1 fund house

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2022 and (b) Audited Consolidated Financial Statements for financial year ended March 31, 2022:
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Soshil Kumar Jain
    1 for0 against
  • Re-appointment of retiring director i.e. Dr. Rajesh Jain
    1 for0 against
  • Ratification of remuneration of M/s GT & Co., Cost Auditors for the financial year 2022-23
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Jun 2026.

  • Tax disputeCentral Excise, New DelhiSince 2 Sep 2010
    The matter is pending before the Delhi High Court. No change during the quarter.
    At the filing before: The Company filed rebate claims of Excise Duty before the Assistant Commsioner of Central Excise which was partly allowed in the form of CENVAT Credit amounting to ₹3.46 million instead of repayment in cash. PBL filed an appeal before Commissioner (Appeals) wherein repayment of claims in cash was allowed and the same was credited into Company's Account. However, Department filed revision application with Joint Secretary, Government of India against the said order which was accepted in favour of Department. Then, the Company filed writ petition before the Delhi High Court against such decision and the same was admitted.MoreLess
  • Tax disputeUnion of India represented through Commissioner of Central GST, Delhi EastSince 8 Feb 2012
    The Company has requested the concerned Deputy Commissioner, CGST (Derabassi) to file suitable application to withdraw the SLP as per the instructions issued by the CBIC under Section 35R of the Central Excise Act 1944, prohibiting filing of appeals etc. by the Department to higher Authorities when the amount of taxes involved is less than the prescribed limits. The matter is pending before the Hon'ble Supreme Court.MoreLess
    At the filing before: Show Cause Notice (SCN) dated 08-02-2012 for ₹12.94 million was issued by Commissioner of Central Excise Chandigarh alleging availment of ineligible CENVAT Credit. The Company filed a Writ Petition for quashing of SCN. Hon’ble High Court of Punjab and Haryana allowed Writ Petition vide Order dated 26-11-2019 and quashed the SCN. Union of India represented through Commissioner of Central GST, Delhi East preferred Special Leave Petition (SLP) before Hon’ble Supreme Court of India on 22-12-2020 against the High Court’s Order.MoreLess
  • Tax disputeCommissioner of Central GST, New DelhiSince 29 Jan 2015
    The matter is pending before the Hon'ble Delhi High Court. No change during the quarter.
    At the filing before: Demand Order of ₹62.50 million with penalty and interest of ₹8.10 million was issued by the Commissioner of Central Excise, Delhi on account of non-payment of service tax u/s 68 on gross value of taxable services. The Company filed an appeal before Customs, Excise & Service Tax Appellate Tribunal, Delhi (“CESTAT”) against the said demand order which was allowed by CESTAT. However, Commissioner of Central GST, New Delhi preferred an appeal before the Hon'ble Delhi High Court (“DHC”) on 30-09-2020 which was rejected vide its order dated 10-09-2024 thereafter. The said Commissioner then filed a Review Petition on 15-11-2024 before DHC against its order.MoreLess
  • Tax disputeDeputy Commissioner of Income Tax, Central Circle-05, New DelhiSince 30 Apr 2021
    The appeal before the Hon'ble Delhi High Court is pending at present. No change during the quarter.
    At the filing before: Demand of ₹33.69 million was raised by Income tax department vide its order dated 30-04-2021 on account of disallowance made by transfer pricing officer on purchases from / payment of expenses to, related parties in Assessment Year 2016-17. The Company filed an appeal before ITAT and case was decided in favour of the Company. Department filed an appeal against the ITAT order before the Hon'ble Delhi High Court.MoreLess
  • Tax disputeDeputy Commissioner of Income Tax, New DelhiSince 10 Oct 2023
    The ITAT allowed the appeal and set aside the order of CIT(Appeals). This results in cancellation of demand of ₹91.6 million.
    At the filing before: Demand of ₹91.6 million was raised by Income Tax department vide its order dated 10-10-2023 on account of disallowance made by assessing officer in Assessment Year 2020-21. The Company filed an appeal before Commissioner of Income Tax (Appeals) ("CIT(Appeals)") which was decided against the Company. The Company filed an appeal with ITAT.MoreLess
  • Tax disputeOffice of the State Tax Officer, MaharashtraSince 16 Jul 2024
    The matter is pending before Deputy Commissioner (Appeals). No change during the quarter.
    At the filing before: Demand of ₹3.8 million was raised on Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. ("PBPL") by GST Department vide its order dated 16-07-2024 for the financial year 2019-20 on account of excess claim of Input Tax Credit of ineligible services and non-payment of GST under reverse charge mechanism on various expenses. PBPL filed an appeal before Deputy Commissioner (Appeals) on 30-09-2024 against the demand order.MoreLess
  • Tax disputeOffice of Assistant Commissioner of State Tax, GST, Porur, Tamil NaduSince 22 Feb 2025
    The appeal before the Deputy Commissoner of State Tax is pending. No change during the quarter.
    At the filing before: Demand of ₹8.81 million was raised by GST Department vide its order dated 22-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST returns for the FY 2020-21. PBPL filed an appeal against the said demand order on 20-05-2025 before the Deputy Commissioner of State Tax, Tamil Nadu.MoreLess
  • Tax disputeOffice of the State Tax Officer, Mazgaon, Mumbai, MaharashtraSince 25 Feb 2025
    PBPL has filed appeal before the GST Appellate Tribunal on 21-07-2026.
    At the filing before: Demand of ₹15.82 million was raised by GST Department vide its order dated 25-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST return for the FY 2020-21. PBPL filed an appeal against the said demand order on 16-05-2025 before the Deputy Commissioner of State Tax, Maharashtra. Order dated 10-03-2026 has been received from Deputy Commissioner of State Tax, Maharashtra reduced total demand from ₹15.82 million to ₹8.15 million.MoreLess
4 more
  • Tax disputeOffice of Assistant Commissioner of Income Tax, DelhiSince 22 Mar 2025
    The Company filed an appeal to ITAT against such order on 13-04-2026.
    At the filing before: Demand of ₹6.36 million was raised by Income Tax department vide its order dated 22-03-2025 on account of disallowance of certain expenditure for the Asesstment Year 2023-24. The Company filed an appeal with CIT(A) against such Order. CIT(A) dismissed the appeal.MoreLess
  • Tax disputeOffice of the Assistant Commissioner of State Tax, GST Bhawan, Mazgaon, Mumbai, MaharashtraSince 10 Jul 2025
    The Company has filed a refund application on 03-04-2026 before Maharashtra GST Authorities for seeking refund of tax & interest paid under protest amounting to ₹31.4 million. The same is currently pending for processing. The matter is pending before the Hon'ble Bombay High Court.MoreLess
    At the filing before: Demand Order of ₹70.34 million was received from the Assistant Commissioner of State Tax, Mumbai towards balance amount of Goods and Service Tax ("GST") (including interest & penalty thereon) on assignment of leasehold rights in land and building by the Company in Navi Mumbai. The Company filed writ petition before the Hon’ble Bombay High Court, challenging the said Order on 04-09-2025. The Hon'ble High Court issued an interim order dated 25-02-2026 pursuant to which the authority has been directed that pending the hearing and final disposal of the petition, no recovery under the impugned orders shall be adopted against the Company.MoreLess
  • Tax disputeOffice of the Commissioner, Central GST (Audit) Commissionerate, PunjabSince 26 Sep 2025
    The Company has filed an appeal before Hon'ble Punjab & Haryana High Cour against the order on 25.06.2026. The matter is pending before the Hon'ble Punjab & Haryana High Court.
    At the filing before: Show cause notice (SCN) was issued under the Central Goods and Services Tax Act, 2017 (CGST Act) regarding alleged non-payment of GST of ₹114.40 million on providing Corporate Guarantee amounting to ₹8,640 million to Debenture Trustee viz. Vistra ITCL (India) Limited in relation to transfer of pharmaceutical formulations business to the Company’s wholly owned subsidiary viz. Panacea Biotec Pharma Limited, for 1,074 days from 06-04-2019 to 15-03-2022. The Company filed writ petition before the Hon’ble Punjab & Haryana High Court on 24-11-2025, challenging the said Order. The Hon'ble High Court passed an interim stay order stating inter-alia that no coercive action be taken against the Company in case of final assessment order is passed or a demand is raised. In the meantime, Joint Commissioner, CGST Sub-Commissionerate Mohali, Chandigarh issued a Demand Order dated 30-03-2026 raising demand aggregating to ~₹228.80 million (towards alleged non-payment of GST of ~₹114.40 million and penalty of ~₹114.40 million).MoreLess
  • Tax disputeAssistant Commissioner of Income Tax, New DelhiSince 24 Dec 2025
    The Company has filed an appeal with ITAT on 11.05.2026.
    At the filing before: Demand aggregating to ₹93.88 million was raised by Income Tax department vide its three Demand Orders dated 24-12-2025, imposing penalty on account of alleged under reporting of income. The Company filed appeals with Commissioner of Income Tax (Appeals) ("CIT(A)") against the said Demand Order. The CIT(A) has dismissed the appeals vide its order dated 25-03-2026.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.